TNFAIP3,which is required for termination of the nuclear factor-κB (NF-κB) signal that is mediated by innate immune receptors, has been reported to be associated with SLE and rheumatoid arthritis [31]. Here, TNFAIP3 is linked to systemic lupus erythematosus.